Saturday, October 10, 2020 7:47:22 AM
Did he? If he did say that he doesn't even know what he took.
"Remsdisivir not a part of it. He specifically said a 2 company cocktail so that eliminates Brilacidin as well."
Still sounds like he doesn't know what he took.
Regeneron’s treatment is a cocktail of two Regeneron antibodies meant to protect against the virus....that was his initial treatment, provided before he was hospitalized.
Lilly’s is a single antibody treatment and Trump wasn't given it.
If you know of a "Regeneron-EI Lily antibody cocktail" please give a link to it or provide a quote and a source from Rush Limbaugh or Sean Hannity or Trump himself or whoever else made it up.
After the initial Regeneron cocktail, and after his hospitalization, he began what was to be a 5 day course of Remdisivir.
Trump has also received dexamethasone, a cheap and widely available corticosteroid that can reduce inflammation. But it also suppresses the immune system, so it's generally not recommended for Covid-19 patients unless the situation is severe.
https://investor.lilly.com/news-releases/news-release-details/lilly-provides-comprehensive-update-progress-sars-cov-2)
https://www.cnn.com/2020/10/05/health/donald-trump-hospital-treatment/index.html
“I have had a wonderful time but this wasn't it.”
..........Groucho
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM